购物车
全部删除
您的购物车当前为空
JAK-IN-14(compound 16)是一种特异性的 JAK1 抑制剂,IC50<5 μM,通过与JAK1的活性位点结合,阻止JAK1的磷酸化,对JAK1 的选择性是JAK2/JAK3的8倍以上,可用于免疫、炎症和肿瘤的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
JAK-IN-14(compound 16)是一种特异性的 JAK1 抑制剂,IC50<5 μM,通过与JAK1的活性位点结合,阻止JAK1的磷酸化,对JAK1 的选择性是JAK2/JAK3的8倍以上,可用于免疫、炎症和肿瘤的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 863 | 现货 | |
| 5 mg | ¥ 1,880 | 现货 | |
| 10 mg | ¥ 2,980 | 现货 | |
| 25 mg | ¥ 4,830 | 现货 | |
| 50 mg | ¥ 6,690 | 现货 | |
| 100 mg | ¥ 8,870 | 现货 | |
| 200 mg | ¥ 12,200 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,980 | 现货 |
JAK-IN-14 相关产品
| 产品描述 | JAK-IN-14 (compound 16) is a specific JAK1 inhibitor with IC50<5 μM. It prevents JAK1 phosphorylation by binding to the active site of JAK1, and is more than 8-fold selective for JAK1 over JAK2/JAK3, and can be used in immune, inflammation and cancer research. |
| 分子量 | 334.35 |
| 分子式 | C19H15FN4O |
| CAS No. | 1973485-06-1 |
| Smiles | N#CCC=1C=CC(=C(F)C1)C2=CC=CC3=NC(=CN32)NC(=O)C4CC4 |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 5 mg/mL (14.95 mM), Sonication and heating are recommended. | ||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.99 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容